MEETINGS - Technomic Publishing will hold the following seminars (US) March - April 1998:
This article was originally published in Clinica
Technomic Publishing will hold two seminars in Boston on the science and technology of designing medical equipment. Designing Neurovascular Devices, on March 30-31, will discuss topics such as applying the principles of neurovascular anatomy and physiology to the design of medical devices; understanding how diseases and injuries affect the neurovascular system; and identifying the regulatory requirements that apply to neurovascular products. Designing Cardiovascular Devices, on April 1-3, will cover the latest advances in cardiovascular devices and current pharmacological and surgical interventions. Contact Technomic in the US for more details. Tel: +1 717 291 5609. Fax: +1 717 295 9637.
You may also be interested in...
Public Company Edition: Lixte’s small uplisting was the only biopharma initial public offering in the US during Thanksgiving week, but IPOs are ramping up again. Also, LifeSci launched its second SPAC and in follow-on offerings Reata brought in $281m and Intellia grossed $175m.
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.